"As part of our ongoing regulatory intelligence activities,
QVigilance team actively monitors websites, newsletters,
and RSS feeds of regulatory authorities and international
standards organisations; as well as reviewing
relevant articles and blogs"
QVigilance continuously monitors regulatory information from local, regional and global authorities and organisations for pharmacovigilance-related regulatory intelligence to ensure that we and our customers are always up to speed and thereby maintain compliance with the latest regulatory requirements and guidelines for both investigational and authorised products.
Advice on pharmacovigilance regulations and guidance in individual countries
Maintaining country-specific and regional case reporting requirements
Maintaining country-specific and regional periodic/aggregate reporting requirements
Support on Local QPPV/representative/safety affiliates requirements globally
5977730031
28 Apr, 2022
European Medicines Agency releases new draft good pharmacovigilance practice guidance on pregnancy prevention programmes and other pregnancy-specific risk minimisation measures. The European Medicines Agency (EMA) has ...
Read More10 Sep, 2020
The United Kingdom (UK) formally left the European Union (EU) on 31 January 2020, since then, there has been a transitionary arrangement in place maintaining the status quo regarding EU regulations on goods and services ...
Read More10 Sep, 2020
The United Kingdom (UK) formally left the European Union (EU) on 31 January 2020 and since that time has been in a transition ‘phase’, during which time the UK and EU have been operating under EU regulations ‘acquis ...
Read More